We can't find the internet
Attempting to reconnect
11111.1;6 IEZ169-LS
Eurostars-Projekt Nr. 4792 AntiFlu - Development of novel clinical drug candidates for the treatment of pandemic and seasonal influenza
Résumé
Eurostars-Projekt Nr. 4792 AntiFlu - Development of novel clinical drug candidates for the treatment of pandemic and seasonal influenza
Textes supplémentaires
Abstract
Starting from recently discovered small molecule inhibitors of the influenza virus polymerase, AntiFlu will deliver a new class of antiviral drug candidates. The novel mechanism of action will ensure broad-spectrum efficacy against both human and avian influenza and minimize resistance development.
Participants
Ulrich Kessler
Kontaktperson
ulrich.kessler@pikepharma.com
Pike Pharma GmbH Ulrich Kessler Wagistrasse 27a 8952 Schlieren ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2009-08-31
- Date de fin
- 2013-10-30
- Coûts totaux approuvés
- CHF 501200.00
- Section
- 15 Bildungsforschung
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- T490 Biotechnology 100.0%